| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 10 |
| 1 | ADALIMUMAB | 9 |
| 2 | ACETAMINOPHEN | 8 |
| 3 | METFORMIN ER 500 MG | 8 |
| 4 | METFORMIN ER 750 MG | 8 |
| 5 | LISINOPRIL | 7 |
| 6 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 5 |
| 7 | AZACITIDINE | 5 |
| 8 | AZACITIDINE FOR | 5 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BELINOSTAT | 1 | 0.0028 |
| 1 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 2 | 0.0018 |
| 2 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 3 | TEPLIZUMAB-MZWV | 1 | 0.0014 |
| 4 | IOPROMIDE | 5 | 0.0012 |
| 5 | GILTERITINIB | 4 | 0.0010 |
| 6 | MIGLUSTAT | 1 | 0.0009 |
| 7 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 3 | 0.0007 |
| 8 | TAZEMETOSTAT | 1 | 0.0006 |
| 9 | ECALLANTIDE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 16 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 2 | Radiographic Contrast Agent [EPC] | 9 |
| 3 | Thalidomide Analog [EPC] | 8 |
| 4 | GLP-1 Receptor Agonist [EPC] | 6 |
| 5 | Expectorant [EPC] | 5 |
| 6 | Kinase Inhibitor [EPC] | 5 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 5 |
| 8 | Sulfonylurea [EPC] | 5 |
| 9 | Benzodiazepine [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 1 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 2 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Radiographic Contrast Agent [EPC] | 9 | 0.0003 |
| 5 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 7 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |